Samuel Ademola Adegoke1, Olufemi Samuel Smith2, Adekunle D Adekile3, Maria Stella Figueiredo4. 1. Haematology and Blood Transfusion Division, Escola Paulista de Medicina, Universidade Federal de Sao Paulo, Brazil; Department of Paediatrics and Child Health, Obafemi Awolowo University, Ile-Ife, Nigeria. Electronic address: adegoke2samade@yahoo.com. 2. Department of Chemical Pathology, Obafemi Awolowo University Teaching Hospital, Ile-Ife, Nigeria. 3. Department of Paediatrics, Faculty of Medicine, Kuwait University, Kuwait. 4. Haematology and Blood Transfusion Division, Escola Paulista de Medicina, Universidade Federal de Sao Paulo, Brazil.
Abstract
BACKGROUND: Alteration in the concentration of inflammatory cytokines may contribute to pathogenesis in sickle cell anaemia (SCA). Vitamin D may suppress pro-inflammatory cytokines and enhance anti-inflammatory cytokines. OBJECTIVE: To compare steady state levels of pro-and anti-inflammatory cytokines of Nigerian SCA children with age- and sex-matched healthy controls, and determine the relationship with 25-hydroxyvitamin-D (25-OHD). Effects of three months of vitamin D supplementation on cytokines of SCA children with suboptimal 25-OHD were also evaluated. METHODS: Serum 25-OHD, IL-1β, 2, 6, 8, 11, 12, 13, 17, 18 of 95 SCA children and 75 matched controls were determined using HPLC. The 12 SCA children with suboptimal 25-OHD received 2000IU of vitamin D daily for 3months, and their post supplementation cytokines and 25-OHD levels were compared with the baseline values. RESULTS: IL-2, 6, 8, 12, 17 and 18 were higher in SCA children than the controls (p≤0.001), but no significant variation in IL-11 and 13 (p=0.131 and 0.057 respectively). Patients with suboptimal serum 25-OHD had higher IL-6, 8 and 18 (p=0.003, 0.010 and 0.002 respectively) and lower levels of IL-11 (p=0.005). Significant positive treatment effects were observed: post-supplementation, serum 25-OHD increased by 23.3ng/mL, p<0.001; proinflammatory cytokines IL-2, 6, 8, 17 and 18 (p<0.001) were reduced and anti-inflammatory cytokine IL-11 was increased, p<0.001. CONCLUSIONS: Suboptimal 25OHD is associated with enhanced levels of pro-inflammatory markers in children with SCA. Three months of daily vitamin D supplementation reversed the trend. Hence; Vitamin D supplementation may reduce the inflammatory milieu and serve as an anti-inflammatory agent in the management of SCA.
BACKGROUND: Alteration in the concentration of inflammatory cytokines may contribute to pathogenesis in sickle cell anaemia (SCA). Vitamin D may suppress pro-inflammatory cytokines and enhance anti-inflammatory cytokines. OBJECTIVE: To compare steady state levels of pro-and anti-inflammatory cytokines of Nigerian SCA children with age- and sex-matched healthy controls, and determine the relationship with 25-hydroxyvitamin-D (25-OHD). Effects of three months of vitamin D supplementation on cytokines of SCA children with suboptimal 25-OHD were also evaluated. METHODS: Serum 25-OHD, IL-1β, 2, 6, 8, 11, 12, 13, 17, 18 of 95 SCA children and 75 matched controls were determined using HPLC. The 12 SCA children with suboptimal 25-OHD received 2000IU of vitamin D daily for 3months, and their post supplementation cytokines and 25-OHD levels were compared with the baseline values. RESULTS:IL-2, 6, 8, 12, 17 and 18 were higher in SCA children than the controls (p≤0.001), but no significant variation in IL-11 and 13 (p=0.131 and 0.057 respectively). Patients with suboptimal serum 25-OHD had higher IL-6, 8 and 18 (p=0.003, 0.010 and 0.002 respectively) and lower levels of IL-11 (p=0.005). Significant positive treatment effects were observed: post-supplementation, serum 25-OHD increased by 23.3ng/mL, p<0.001; proinflammatory cytokines IL-2, 6, 8, 17 and 18 (p<0.001) were reduced and anti-inflammatory cytokine IL-11 was increased, p<0.001. CONCLUSIONS: Suboptimal 25OHD is associated with enhanced levels of pro-inflammatory markers in children with SCA. Three months of daily vitamin D supplementation reversed the trend. Hence; Vitamin D supplementation may reduce the inflammatory milieu and serve as an anti-inflammatory agent in the management of SCA.
Authors: Adekunle E Alagbe; Igor F Domingos; Adekunle D Adekile; Maria H S L Blotta; Magnun N N Santos Journal: Mol Biol Rep Date: 2022-01-09 Impact factor: 2.316
Authors: Katarzyna Kasprowicz; Wojciech Ratkowski; Wojciech Wołyniec; Mariusz Kaczmarczyk; Konrad Witek; Piotr Żmijewski; Marcin Renke; Zbigniew Jastrzębski; Thomas Rosemann; Pantelis T Nikolaidis; Beat Knechtle Journal: Int J Environ Res Public Health Date: 2020-04-24 Impact factor: 3.390
Authors: Cyrielle Holuka; Myriam P Merz; Sara B Fernandes; Eleftheria G Charalambous; Snehaa V Seal; Nathalie Grova; Jonathan D Turner Journal: Int J Mol Sci Date: 2020-07-19 Impact factor: 5.923
Authors: Elena María Rincón-López; María Luisa Navarro Gómez; Teresa Hernández-Sampelayo Matos; David Aguilera-Alonso; Eva Dueñas Moreno; Jesús Saavedra-Lozano; Begoña Santiago García; María Del Mar Santos Sebastián; Marina García Morín; Cristina Beléndez Bieler; Jorge Lorente Romero; Elena Cela de Julián Journal: BMC Infect Dis Date: 2021-08-03 Impact factor: 3.090